Russell Investments Group’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $288K | Buy |
62,313
+60,870
| +4,218% | +$230K | ﹤0.01% | 3033 |
|
|
2026
Q1 | $4.17K | Buy |
1,443
+166
| +13% | +$354 | ﹤0.01% | 3924 |
|
|
2025
Q4 | $2.06K | Sell |
1,277
-47,828
| -97% | -$75.2K | ﹤0.01% | 4003 |
|
|
2025
Q3 | $85.8K | Sell |
49,105
-459
| -0.9% | -$743 | ﹤0.01% | 3082 |
|
|
2025
Q2 | $59K | Buy |
49,564
+47,950
| +2,971% | +$69.6K | ﹤0.01% | 2940 |
|
|
2025
Q1 | $2.05K | Buy |
1,614
+28
| +2% | +$73 | ﹤0.01% | 3515 |
|
|
2024
Q4 | $5.16K | Sell |
1,586
-14,528
| -90% | -$52.3K | ﹤0.01% | 3282 |
|
|
2024
Q3 | $53K | Sell |
16,114
-2,276
| -12% | -$8.87K | ﹤0.01% | 2779 |
|
|
2024
Q2 | $78.2K | Buy |
18,390
+2,432
| +15% | +$23.7K | ﹤0.01% | 2680 |
|
|
2024
Q1 | $235K | Buy |
15,958
+616
| +4% | +$9.31K | ﹤0.01% | 2407 |
|
|
2023
Q4 | $148K | Sell |
15,342
-13,645
| -47% | -$94.3K | ﹤0.01% | 2491 |
|
|
2023
Q3 | $135K | Sell |
28,987
-5,484
| -16% | -$27.3K | ﹤0.01% | 2567 |
|
|
2023
Q2 | $184K | Buy |
34,471
+14,307
| +71% | +$88.3K | ﹤0.01% | 2488 |
|
|
2023
Q1 | $145K | Sell |
20,164
-18,116
| -47% | -$109K | ﹤0.01% | 2532 |
|
|
2022
Q4 | $257K | Sell |
38,280
-37,600
| -50% | -$206K | ﹤0.01% | 2507 |
|
|
2022
Q3 | $261K | Buy |
75,880
+46,300
| +157% | +$177K | ﹤0.01% | 2474 |
|
|
2022
Q2 | $86K | Buy |
29,580
+14,900
| +101% | +$78.3K | ﹤0.01% | 2681 |
|
|
2022
Q1 | $129K | Hold |
14,680
| – | – | ﹤0.01% | 2529 |
|
|
2021
Q4 | $235K | Hold |
14,680
| – | – | ﹤0.01% | 2682 |
|
|
2021
Q3 | $307K | Sell |
14,680
-45,868
| -76% | -$1.1M | ﹤0.01% | 2641 |
|
|
2021
Q2 | $1.63M | Sell |
60,548
-36,847
| -38% | -$1.08M | ﹤0.01% | 2041 |
|
|
2021
Q1 | $3.1M | Buy |
97,395
+29,069
| +43% | +$706K | 0.01% | 1622 |
|
|
2020
Q4 | $1.56M | Sell |
68,326
-19,542
| -22% | -$450K | ﹤0.01% | 1889 |
|
|
2020
Q3 | $2.21M | Buy |
87,868
+25,152
| +40% | +$687K | ﹤0.01% | 1616 |
|
|
2020
Q2 | $1.75M | Buy |
62,716
+8,246
| +15% | +$143K | ﹤0.01% | 1716 |
|
|
2020
Q1 | $316K | Buy |
+54,470
| New | +$495K | ﹤0.01% | 2371 |
|
|
2019
Q3 | – | Sell |
-45,286
| Closed | -$768K | – | 3069 |
|
|
2019
Q2 | $768K | Hold |
45,286
| – | – | ﹤0.01% | 2097 |
|
|
2019
Q1 | $813K | Buy |
+45,286
| New | +$783K | ﹤0.01% | 2172 |
|
|
2018
Q3 | – | Sell |
-22,200
| Closed | -$458K | – | 2992 |
|
|
2018
Q2 | $458K | Buy |
22,200
+5,600
| +34% | +$126K | ﹤0.01% | 2420 |
|
|
2018
Q1 | $418K | Buy |
16,600
+6,500
| +64% | +$158K | ﹤0.01% | 2519 |
|
|
2017
Q4 | $196K | Buy |
10,100
+7,200
| +248% | +$134K | ﹤0.01% | 2673 |
|
|
2017
Q3 | $54K | Sell |
2,900
-4,681
| -62% | -$81.1K | ﹤0.01% | 2850 |
|
|
2017
Q2 | $133K | Buy |
+7,581
| New | +$145K | ﹤0.01% | 2767 |
|
|
2017
Q1 | – | Sell |
-9,252
| Closed | -$186K | – | 3039 |
|
|
2016
Q4 | $186K | Buy |
+9,252
| New | +$233K | ﹤0.01% | 2729 |
|
Other funds holding MGNX
WA
PA
PAM
SO
PAP
Russell Investments Group's MGNX Position: Q2 2026 in Review
Russell Investments Group increased its MacroGenics (MGNX) stake by 4,218% in Q2 2026, buying an estimated $230K and bringing the position to 62,313 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #3033.
Russell Investments Group first reported a position in MGNX in Q4 2016 and has held it in 34 quarters since. The position peaked at $3.1M in Q1 2021. 31 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.
- Russell Investments Group held 62,313 shares of MacroGenics worth $288K as of Q2 2026.
- Russell Investments Group bought 60,870 MacroGenics shares in Q2 2026, an estimated $230K.
- MacroGenics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3033 holding.
- Russell Investments Group first reported a position in MacroGenics in Q4 2016 and has held it in 34 quarters since.
- Russell Investments Group's MacroGenics position peaked at $3.1M in Q1 2021.
- 31 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.